$MFC · MANULIFE FINANCIAL CORP
Manulife reported Q3 2026 results (period ended September 30, 2026) with record core earnings of $2.1B, up 4% on a CER basis, and core EPS of $1.24, up 6%. Net income attributed to shareholders fell 22% to $1.4B, with EPS of $0.82 down 21%, driven by a larger net charge on market experience and a net charge from Vietnam operations. Core ROE was 17.8%, LICAT ratio 136%, and Global WAM saw net outflows of $3.6B (improved from $6.2B in 3Q25). The company returned $1.3B to shareholders and completed its annual actuarial review with a net favourable $128M impact.
- Core earnings of $2.1B, up 4% CER; core EPS $1.24, up 6%
- Net income attributed to shareholders $1.4B, down 22%; EPS $0.82, down 21%
- Core ROE 17.8%; LICAT ratio 136%
- Global WAM net outflows $3.6B vs $6.2B in 3Q25
- Returned $1.3B to shareholders; actuarial review net favourable $128M
Extended-hours last trade $45.34, down 1.28% vs regular close and 1.36% vs price-at-filing, suggesting a mildly negative after-hours reaction despite record core earnings.
Record core earnings and a 6% core EPS gain contrast with a 22% net income drop, highlighting the gap between Manulife's operating strength and market-driven charges.
Manulife's double-digit Asia core earnings growth (17%) and private-credit fundraise (US$5.4B Comvest Credit Partners VII) underscore the sector's pivot toward Asia and alternative assets.
Net charge on market experience from lower-than-expected returns on alternative long-duration assets (private equity, real estate, farmland) and public equities; net charge from Vietnam operations including a partial bancassurance impairment.